Orthodontic treatment with clear aligner
DeviceIncluded orthodontic treatment with clear aligner (eon Aligners)
NCT Number: NCT04107012
Development of white spot lesions (enamel demineralization) will be evaluated quantitatively during clear aligner orthodontic treatment compared to conventional fixed appliances using quantitative light induced fluorescence (QLF)
Looking for future studies?
Notify Me17 year–24 year
All sexes
Interventional
Not applicable
White spot lesion (WSL) may develop around fixed orthodontic appliances. With clear aligners, however, the issue is not controversial. WSL will be monitored in 2 groups of patients; one group using clear aligners and one group wearing fixed orthodontic appliances for 3 months. QLF images will be taken before treatment (T0) and 3 months after commencement of the treatment (T1). The results will be compared between the two groups
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-Patients with poor oral hygiene, defective enamel, extensive restorations and salivary glands diseases were excluded.
Included orthodontic treatment with clear aligner (eon Aligners)
Time frame: 3 months
Incideance of Fluorescence loss
Time frame: 3 months
Incidence of the white spot lesion area
Time frame: 3 months
The number of newly developed white spot lesion during orthodontic treatment
Time frame: 3 months
Rate of plaque on tooth surfaces
Jordan University of Science and Technology
Other
Evaluation of Enamel Demineralization During Clear Aligner Orthodontic Treatment With QLF Compared to Conventional Fixed Appliances: a Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05738369
White Spot Lesion
Irbid, Jordan
View Trial DetailsNCT06166849
White Spot Lesion
Cluj-Napoca, Romania
View Trial DetailsNCT06131294
White Spot Lesion
Istanbul, Esenler, Turkey (Türkiye)
View Trial DetailsNCT06566833
White Spot Lesion
Alexandria, Professor, Egypt
View Trial Details